BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10829309)

  • 21. The genetics and genomics of cancer.
    Balmain A; Gray J; Ponder B
    Nat Genet; 2003 Mar; 33 Suppl():238-44. PubMed ID: 12610533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of somatic SDHD mutations in sporadic neuroendocrine tumors and detection of two germline variants in paraganglioma patients.
    Perren A; Barghorn A; Schmid S; Saremaslani P; Roth J; Heitz PU; Komminoth P
    Oncogene; 2002 Oct; 21(49):7605-8. PubMed ID: 12386824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular basis of cancer].
    Meza-Junco J; Montaño-Loza A; Aguayo-González A
    Rev Invest Clin; 2006; 58(1):56-70. PubMed ID: 16789600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acquired mutations--basic cancer biology].
    Grønbaek K; Guldberg P
    Ugeskr Laeger; 2006 Jun; 168(24):2335-8. PubMed ID: 16822414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is cancer a hereditary or a degenerative disease?].
    Cassiman JJ
    Verh K Acad Geneeskd Belg; 2001; 63(2):137-52. PubMed ID: 11436418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary colorectal cancer syndromes.
    Guanti G; Bukvić N
    Acta Chir Iugosl; 2000; 47(4 Suppl 1):23-5. PubMed ID: 11432238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular cancer biology--from research to clinical practice].
    Nielsen FC
    Ugeskr Laeger; 2003 Feb; 165(9):897-900. PubMed ID: 12661511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic possibilities and opportunities for comparative oncopathology.
    Kaiser HE
    In Vivo; 1993; 7(6A):553-65. PubMed ID: 8193276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome abnormalities as primary events in human malignant disease: evidence from marker chromosomes.
    Atkin NB; Baker MC
    J Natl Cancer Inst; 1966 Mar; 36(3):539-57. PubMed ID: 18630328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
    Gimm O; Armanios M; Dziema H; Neumann HP; Eng C
    Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic stability and tumorigenesis.
    Sieber O; Heinimann K; Tomlinson I
    Semin Cancer Biol; 2005 Feb; 15(1):61-6. PubMed ID: 15613289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Early diagnosis of neoplasms].
    Müller H
    Bull Schweiz Akad Med Wiss; 1978 Nov; 34(4-6):389-400. PubMed ID: 728676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of apoptosis regulators in tumorigenesis.
    Malaguarnera L
    Cancer Metastasis Rev; 2004; 23(3-4):367-87. PubMed ID: 15197336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.